These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 30714240)

  • 1. Use of the self-controlled case series method in drug safety assessment.
    Grosso A; Douglas I; MacAllister R; Petersen I; Smeeth L; Hingorani AD
    Expert Opin Drug Saf; 2011 May; 10(3):337-40. PubMed ID: 21406031
    [No Abstract]   [Full Text] [Related]  

  • 2. Disease latency and new-user versus prevalent-user cohort designs: Implications for pharmacoepidemiology in dementia.
    Wu CY; Swardfager W
    J Am Geriatr Soc; 2024 Mar; 72(3):953-955. PubMed ID: 38147492
    [No Abstract]   [Full Text] [Related]  

  • 3. Reply to: Disease latency and new-user versus prevalent-user cohort designs: Implications for pharmacoepidemiology in dementia.
    Lee AK; Lee SJ; Dublin S
    J Am Geriatr Soc; 2024 Mar; 72(3):956-957. PubMed ID: 38147504
    [No Abstract]   [Full Text] [Related]  

  • 4. What Is Pharmacoepidemiology and How Does It Inform Clinical Care?
    Hillen J
    Sr Care Pharm; 2024 Jul; 39(7):240-241. PubMed ID: 38937892
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy.
    Huybrechts KF; Bateman BT; Hernández-Díaz S
    Pharmacoepidemiol Drug Saf; 2019 Jul; 28(7):906-922. PubMed ID: 31074570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidance of development, validation, and evaluation of algorithms for populating health status in observational studies of routinely collected data (DEVELOP-RCD).
    Wang W; Jin YH; Liu M; He Q; Xu JY; Wang MQ; Li GW; Fu B; Yan SY; Zou K; Sun X
    Mil Med Res; 2024 Aug; 11(1):52. PubMed ID: 39107834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the Capture-Recapture Method to Estimate the Frequency of Community- and Hospital-Acquired Drug-Induced Acute Kidney Injuries in French Databases.
    Rey A; Gras V; Moragny J; Choukroun G; Masmoudi K; Liabeuf S
    Front Pharmacol; 2022; 13():899164. PubMed ID: 35865950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validity of Administrative Data for Identifying Birth-Related Outcomes with the End Date of Pregnancy in a Japanese University Hospital.
    Tajima K; Ishikawa T; Matsuzaki F; Noda A; Morishita K; Inoue R; Iwama N; Nishigori H; Sugawara J; Saito M; Obara T; Mano N
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of coding algorithms for identifying people with viral hepatitis using claims data according to different standard references.
    Sheu MJ; Chin TW; Ku FP; Li CY; Li ST; Lu TH
    BMC Infect Dis; 2022 Mar; 22(1):222. PubMed ID: 35246067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of ICD-10-CM Codes Used to Identify Patients with Chronic Hepatitis B and C Virus Infection in Administrative Claims Data from the Taiwan National Health Insurance Outpatient Claims Dataset.
    Sheu MJ; Liang FW; Li ST; Li CY; Lu TH
    Clin Epidemiol; 2020; 12():185-192. PubMed ID: 32110110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodological considerations when analysing and interpreting real-world data.
    Stürmer T; Wang T; Golightly YM; Keil A; Lund JL; Jonsson Funk M
    Rheumatology (Oxford); 2020 Jan; 59(1):14-25. PubMed ID: 31834408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia.
    ; Andersen M; Bergman U; Choi NK; Gerhard T; Huang C; Jalbert J; Kimura M; Kimura T; Kubota K; Lai EC; Ooba N; Park BJ; Pratt N; Roughead EE; Sato T; Setoguchi S; Shin JY; Sundström A; Yang YH
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):700-4. PubMed ID: 23653370
    [No Abstract]   [Full Text] [Related]  

  • 13. Significance of data mining in routine signal detection: Analysis based on the safety signals identified by the FDA.
    Fukazawa C; Hinomura Y; Kaneko M; Narukawa M
    Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1402-1408. PubMed ID: 30324671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research in pharmacoepidemiology in Iceland].
    Johannsson M; Haraldsdottir S
    Laeknabladid; 2012 Apr; 98(4):217-22. PubMed ID: 22460435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
    Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoepidemiology and Drug Safety's special issue on validation studies.
    Chun DS; Lund JL; Stürmer T
    Pharmacoepidemiol Drug Saf; 2019 Feb; 28(2):123-125. PubMed ID: 30714240
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases.
    Maignen F; Hauben M; Hung E; Van Holle L; Dogne JM
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):195-207. PubMed ID: 24243665
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.